DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
CN |
|
M
|
Microstrategy Inc
F:MIGA
|
US |
|
Grifols SA
LSE:0RDU
|
ES |
|
Airports of Thailand PCL
OTC:AIPUY
|
TH |
|
C
|
China Vast Industrial Urban Development Company Ltd
HKEX:6166
|
HK |
|
W
|
Wharf Holdings Ltd
OTC:WARFF
|
HK |
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
W
|
Wasco Bhd
KLSE:WASCO
|
MY |
|
Mercer International Inc
NASDAQ:MERC
|
CA |
|
Unico Silver Ltd
ASX:USL
|
AU |
Dividends
Dividend Yield
DaShenLin Pharmaceutical Group Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
DaShenLin Pharmaceutical Group Co Ltd
Payout Ratio
DaShenLin Pharmaceutical Group Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for DaShenLin Pharmaceutical Group Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
DaShenLin Pharmaceutical Group Co Ltd
| Average Annual Return | -20.91% |
| Standard Deviation of Annual Returns | 29.2% |
| Max Drawdown | -74% |
| Market Capitalization | 18.7B CNY |
| Shares Outstanding | 1 138 850 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
DaShenLin Pharmaceutical Group Co Ltd's latest stock split occurred on Jun 9, 2023
The company executed a 6-for-5 stock split, meaning that for every 5 shares held, investors received 6 new shares.
Before the split, DaShenLin Pharmaceutical Group Co Ltd traded at 26.3583 per share. Afterward, the share price was about 26.84.
The adjusted shares began trading on Jun 9, 2023. This was stock split number 5 in DaShenLin Pharmaceutical Group Co Ltd's history, following the previous one in Jun 13, 2022.
